ConductScience.org, home

Trial · NCT06501807

BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry

NCT06501807, Not applicable, Recruiting, University Hospital, Lille

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry. Trials, record NCT06501807. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06501807

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry
NCT number
NCT06501807
Status
Recruiting
Phases
Not applicable
Enrollment
900 participants, estimated
Lead sponsor
University Hospital, Lille
Conditions
Rhinosinusitis Chronic, Nasal Polyps
Interventions
Biologic treatments available in Chronic Rhinosinusitis with Nasal Polyps (dupilumab, mepolizumab and benralizumab according to their marketing approval).
First posted
2024-07-15
Last updated
2026-05-18

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryComparison of quality of life over 5 years according to the asthmatic status of the patients5-year follow-upAssessment of disease control with the Sino-nasal outcome test-22. from 0 to 110, 110=worst outcome
SecondaryQuality of life progression in patients with Chronic Rhinosinusitis with Nasal PolypsEvaluation after 6 months of treatment with biologicsAssessment of disease control with the Sino-nasal outcome test-22. from 0 to 110, 110=worst outcome
SecondaryPatient reported symptoms measurementMonth 0, Month 3, Month 6, and every 6 months until 5 yearsNumber of oral corticosteroid treatment courses between each visit (in grammes)
SecondaryTime to first surgical procedure since the beginning of biologic treatmentMMonth 0, Month 3, Month 6, and every 6 months until 5 yearsDate and type of sinus surgery between each visit
SecondaryBlood eosinophil count and total IgE blood concentrations evolution during the course of the 5-year follow-upMonth 0, Month 3, Month 6, and every 6 months until 5 yearsNumber off cells per mm3

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06501807

GET https://conductscience.org/api/trials/v1/NCT06501807/registered